Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and Atrial Fibrillation

olmesartan has been researched along with Atrial Fibrillation in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, ZY; Huang, K; Pan, C; Zhang, H; Zhang, J; Zhong, Y; Zhu, LL1
Goette, A; Güvenir, HA; Karaagaoglu, E; Katircioglu-Öztürk, D; Meinertz, T; Okutucu, S; Oto, A; Oto, E1
Fukaya, H; Hirasawa, S; Izumi, T; Kiryu, M; Masaki, Y; Moriguchi, M; Niwano, H; Niwano, S; Sato, D1
Breithardt, G; Fetsch, T; Goette, A; Häusler, KG; Kirchhof, P; Klein, HU; Meinertz, T; Schön, N; Steinbeck, G; Wegscheider, K1
Aoyama, Y; Fukaya, H; Izumi, T; Kiryu, M; Kishihara, J; Masaki, Y; Niwano, H; Niwano, S1
Goette, A; Lendeckel, U; Wolke, C1
Aizawa, T; Iinuma, H; Iwasaki, YK; Kato, T; Sagara, K; Sawada, H; Sekiguchi, A; Tsuneda, T; Yamashita, T1
Kumagai, K; Nakashima, H1

Trials

3 trial(s) available for olmesartan and Atrial Fibrillation

ArticleYear
Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients.
    Chinese medical journal, 2016, 09-20, Volume: 129, Issue:18

    Topics: Aged; Angiotensin Receptor Antagonists; Atrial Fibrillation; Atrioventricular Block; Female; Humans; Imidazoles; Male; Middle Aged; Single-Blind Method; Tetrazoles

2016
Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: 'exposing the invisible'.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2017, May-01, Volume: 19, Issue:5

    Topics: Age Distribution; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Comorbidity; Data Mining; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Incidence; Male; Middle Aged; Prevalence; Risk Factors; Sex Distribution; Tetrazoles; Treatment Outcome; Turkey

2017
Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
    Circulation. Arrhythmia and electrophysiology, 2012, Volume: 5, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Germany; Humans; Imidazoles; Incidence; Male; Middle Aged; Prospective Studies; Tachycardia, Paroxysmal; Tetrazoles; Time Factors; Treatment Outcome

2012

Other Studies

5 other study(ies) available for olmesartan and Atrial Fibrillation

ArticleYear
Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model.
    International journal of cardiology, 2012, May-31, Volume: 157, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Disease Models, Animal; Dogs; Down-Regulation; Drug Therapy, Combination; Heart Conduction System; Imidazoles; Tetrazoles; Up-Regulation

2012
Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2012, Volume: 14, Issue:8

    Topics: Angiotensin II; Animals; Atrial Fibrillation; Blotting, Western; Connective Tissue Growth Factor; Disease Models, Animal; Dogs; Extracellular Matrix; Female; Heart Atria; Imidazoles; Real-Time Polymerase Chain Reaction; Signal Transduction; Tetrazoles; Up-Regulation

2012
Atrial fibrillation and fibrosis: role of connective tissue growth factor.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2012, Volume: 14, Issue:8

    Topics: Angiotensin II; Animals; Atrial Fibrillation; Connective Tissue Growth Factor; Female; Heart Atria; Imidazoles; Tetrazoles

2012
Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2007, Volume: 8, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Down-Regulation; Endocardium; Heart Atria; Heart Diseases; Imidazoles; Immunohistochemistry; Lipoproteins; Myocardium; Nitric Oxide Synthase Type III; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Thrombomodulin; Up-Regulation

2007
Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Fibrillation; Cardiac Electrophysiology; Disease Models, Animal; Dogs; Female; Heart Conduction System; Heart Rate; Imidazoles; Male; Myocardial Contraction; Myocardium; Secondary Prevention; Tetrazoles

2007